High efficient inflammation-resistant multi-enzyme composition

An enzyme composition, high-efficiency technology, applied in the direction of anti-inflammatory agents, drug combinations, food science, etc., can solve the problems that have not been reported in the application, achieve no immunogenicity, good anti-inflammatory effect, prevention and treatment of vascular embolism effect of disease

Inactive Publication Date: 2016-12-14
安徽瑞达健康产业有限公司
View PDF7 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0013] At present, the combination of glutathione, natto freeze-dried powder, potato extract and protease in the prevention and treatment of inflammation has not been reported

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • High efficient inflammation-resistant multi-enzyme composition
  • High efficient inflammation-resistant multi-enzyme composition
  • High efficient inflammation-resistant multi-enzyme composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] Embodiment 1: oral tablet

[0036] Taking the production of 200 tablets of the present invention as an example, raw materials used and auxiliary materials and their quality proportions are as follows:

[0037]

[0038] The preparation process is carried out according to the conventional process of pharmacy tablets, each tablet weighs 0.75 g, and each tablet contains 80 mg of trypsin, 30 mg of papain, 45 mg of bromelain, 22 mg of trypsin and 1 mg of chymotrypsin.

Embodiment 2

[0039] Embodiment 2: oral tablet

[0040] Taking the production of 200 tablets of the present invention as an example, raw materials used and auxiliary materials and their quality proportions are as follows:

[0041]

[0042] The preparation process is carried out according to the conventional process of pharmacy tablets, each tablet weighs 0.75 g, and each tablet contains 80 mg of trypsin, 30 mg of papain, 45 mg of bromelain, 22 mg of trypsin and 1 mg of chymotrypsin.

Embodiment 3

[0043] Embodiment 3: oral tablet

[0044] Taking the production of 200 tablets of the present invention as an example, raw materials used and auxiliary materials and their quality proportions are as follows:

[0045]

[0046]

[0047] The preparation process is carried out according to the conventional process of pharmacy tablets, each tablet weighs 0.75 g, and each tablet contains 80 mg of trypsin, 30 mg of papain, 45 mg of bromelain, 22 mg of trypsin and 1 mg of chymotrypsin.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the fields of medicine and health care products, and specifically relates to a high efficient inflammation-resistant multi-enzyme composition. The multi-enzyme composition comprises one or more proteases and also comprises potato extract, glutathione, and natto freeze-dried powder. The provided composition can be made into tablets, hard capsules, soft capsules, or granules, and can also be made into medicinal preparations, health care products, and functional food. In the composition, potato extract, glutathione, natto freeze-dried powder, and protease generate a synergetic effect, a better anti-inflammation is achieved, compared with the conventional multi-enzyme compositions, and the time of the recovery phase is prominently shortened.

Description

technical field [0001] The invention relates to the fields of medicine and health products, in particular to a high-efficiency anti-inflammatory multi-enzyme composition. Background technique [0002] Enzymes are a class of biologically active macromolecular substances from organisms, which have the characteristics of specificity, specificity, and mildness. The proteolytic enzyme composition has obvious anti-inflammatory effect, has been widely accepted by the medical circle, and has a large amount of clinical data. It has been reported that using one enzyme alone can anti-inflammation, but the combined effect of two or more proteases is better. Although most hydrolytic enzymes can play a role in treating inflammation, there are differences in the mechanism. Each enzyme performs its own duties and cooperates with each other to better treat inflammation. [0003] Bromelain is a proteolytic enzyme extracted from pineapple, belonging to cysteine ​​protease, which can hydrolyz...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/48A61K36/81A61K36/48A61K38/06A61P29/00A61K31/7048A61K31/352A23L33/10A23L33/105A23L33/18A23L11/00A23L33/16A23L11/50
CPCA61K38/063A61K38/48A61K38/4826A61K31/352A61K31/7048A61K36/48A61K36/81A23V2002/00A61K2300/00A23V2200/324A23V2200/32A23V2200/30A23V2250/21
Inventor 刘丹宣坚刚宋瑞王明月杨亮汤伟强顾大业吴阳洋
Owner 安徽瑞达健康产业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap